374 related articles for article (PubMed ID: 25959868)
1. Yes-Associated Protein is up-regulated by mechanical overload and is sufficient to induce skeletal muscle hypertrophy.
Goodman CA; Dietz JM; Jacobs BL; McNally RM; You JS; Hornberger TA
FEBS Lett; 2015 Jun; 589(13):1491-7. PubMed ID: 25959868
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 promotes denervation-induced muscle atrophy through a mechanism involving the activation of FoxO and E3 ubiquitin ligases.
Tang H; Inoki K; Lee M; Wright E; Khuong A; Khuong A; Sugiarto S; Garner M; Paik J; DePinho RA; Goldman D; Guan KL; Shrager JB
Sci Signal; 2014 Feb; 7(314):ra18. PubMed ID: 24570486
[TBL] [Abstract][Full Text] [Related]
3. Nutrient-induced stimulation of protein synthesis in mouse skeletal muscle is limited by the mTORC1 repressor REDD1.
Gordon BS; Williamson DL; Lang CH; Jefferson LS; Kimball SR
J Nutr; 2015 Apr; 145(4):708-13. PubMed ID: 25716553
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of CaMKKα signaling is sufficient but not necessary for mTORC1 activation and growth in mouse skeletal muscle.
Ferey JL; Brault JJ; Smith CA; Witczak CA
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E686-94. PubMed ID: 25159322
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin E3 ligase Atrogin-1 protein is regulated via the rapamycin-sensitive mTOR-S6K1 signaling pathway in C2C12 muscle cells.
Nishimura Y; Chunthorng-Orn J; Lord S; Musa I; Dawson P; Holm L; Lai YC
Am J Physiol Cell Physiol; 2022 Jul; 323(1):C215-C225. PubMed ID: 35704697
[TBL] [Abstract][Full Text] [Related]
6. Early activation of mTORC1 signalling in response to mechanical overload is independent of phosphoinositide 3-kinase/Akt signalling.
Miyazaki M; McCarthy JJ; Fedele MJ; Esser KA
J Physiol; 2011 Apr; 589(Pt 7):1831-46. PubMed ID: 21300751
[TBL] [Abstract][Full Text] [Related]
7. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
[TBL] [Abstract][Full Text] [Related]
8. Smad2 and 3 transcription factors control muscle mass in adulthood.
Sartori R; Milan G; Patron M; Mammucari C; Blaauw B; Abraham R; Sandri M
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1248-57. PubMed ID: 19357234
[TBL] [Abstract][Full Text] [Related]
9. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of the Hippo Pathway Component AMOTL2 by the mTORC2 Kinase Promotes YAP Signaling, Resulting in Enhanced Glioblastoma Growth and Invasiveness.
Artinian N; Cloninger C; Holmes B; Benavides-Serrato A; Bashir T; Gera J
J Biol Chem; 2015 Aug; 290(32):19387-401. PubMed ID: 25998128
[TBL] [Abstract][Full Text] [Related]
11. Smad3 induces atrogin-1, inhibits mTOR and protein synthesis, and promotes muscle atrophy in vivo.
Goodman CA; McNally RM; Hoffmann FM; Hornberger TA
Mol Endocrinol; 2013 Nov; 27(11):1946-57. PubMed ID: 24002653
[TBL] [Abstract][Full Text] [Related]
12. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids.
Dickinson JM; Fry CS; Drummond MJ; Gundermann DM; Walker DK; Glynn EL; Timmerman KL; Dhanani S; Volpi E; Rasmussen BB
J Nutr; 2011 May; 141(5):856-62. PubMed ID: 21430254
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
Kim M; Kim T; Johnson RL; Lim DS
Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
[TBL] [Abstract][Full Text] [Related]
15. Pathological hypertrophy amelioration by PRAS40-mediated inhibition of mTORC1.
Völkers M; Toko H; Doroudgar S; Din S; Quijada P; Joyo AY; Ornelas L; Joyo E; Thuerauf DJ; Konstandin MH; Gude N; Glembotski CC; Sussman MA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12661-6. PubMed ID: 23842089
[TBL] [Abstract][Full Text] [Related]
16. The cochaperone BAG3 coordinates protein synthesis and autophagy under mechanical strain through spatial regulation of mTORC1.
Kathage B; Gehlert S; Ulbricht A; Lüdecke L; Tapia VE; Orfanos Z; Wenzel D; Bloch W; Volkmer R; Fleischmann BK; Fürst DO; Höhfeld J
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):62-75. PubMed ID: 27756573
[TBL] [Abstract][Full Text] [Related]
17. The regulation of polyamine pathway proteins in models of skeletal muscle hypertrophy and atrophy: a potential role for mTORC1.
Tabbaa M; Ruz Gomez T; Campelj DG; Gregorevic P; Hayes A; Goodman CA
Am J Physiol Cell Physiol; 2021 Jun; 320(6):C987-C999. PubMed ID: 33881936
[TBL] [Abstract][Full Text] [Related]
18. Molecular brakes regulating mTORC1 activation in skeletal muscle following synergist ablation.
Hamilton DL; Philp A; MacKenzie MG; Patton A; Towler MC; Gallagher IJ; Bodine SC; Baar K
Am J Physiol Endocrinol Metab; 2014 Aug; 307(4):E365-73. PubMed ID: 24961241
[TBL] [Abstract][Full Text] [Related]
19. The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.
Watt KI; Turner BJ; Hagg A; Zhang X; Davey JR; Qian H; Beyer C; Winbanks CE; Harvey KF; Gregorevic P
Nat Commun; 2015 Jan; 6():6048. PubMed ID: 25581281
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional coactivator PGC-1α is dispensable for chronic overload-induced skeletal muscle hypertrophy and metabolic remodeling.
Pérez-Schindler J; Summermatter S; Santos G; Zorzato F; Handschin C
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20314-9. PubMed ID: 24277823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
